Results 141 to 150 of about 5,500,616 (251)
Supplementary table -Supplemental material for Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals
, 2018 Supplemental material, Supplementary table for Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals by Veronika Pietsch, Katja Deterding, Dina Attia ...Michael Gebel (5499044), Dina Attia (5499047), Heiner Wedemeyer (32361), Markus Cornberg (32357), Michael Peter Manns (220587), Veronika Pietsch (5499050), Benjamin Heidrich (345028), Kristina Imeen Ringe (716653), Katja Deterding (4967791), Andrej Potthoff (5499041) +9 morecore +1 more sourceSerum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All‐Cause Mortality After SVR in Advanced Chronic Hepatitis C
Hepatology Research, EarlyView.ABSTRACT Background and Aims
Patients with chronic hepatitis C and advanced fibrosis remain at substantial risk of hepatocellular carcinoma (HCC) and non‐liver–related death even after sustained virological response (SVR) to direct‐acting antivirals (DAA).Daisuke Sakon, Jumpei Kondo, Yuki Tahata, Hayato Hikita, Maki Iwaisako, Muya Matsumoto, Asuka Ogata, Shinji Takamatsu, Yasutoshi Nozaki, Naruyasu Kakita, Hisashi Ishida, Fumihiko Nakanishi, Yuichi Yoshida, Masanori Nakahara, Kazuho Imanaka, Mitsuru Sakakibara, Takayuki Yakushijin, Tetsuo Takehara, Takahiro Kodama, Eiji Miyoshi +19 morewiley +1 more sourcePatient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients
, 2020 Background. Hepatitis C (HCV) treatment efficacy among HIV patients is limited by poor treatment adherence and tolerance, but few studies have examined the psychosocial determinants of treatment adherence and outcomes. Methods.Mallory Witt, Karen Chan Osilla, Laveeza Bhatti, Glenn Wagner, Jeffrey Garnett, Bonnie Ghosh-Dastidar, Matthew Bidwell Goetz +6 morecore Clinical Outcomes of Gradual Corticosteroid Tapering for Immune Checkpoint Inhibitor‐Induced Liver Injury
Hepatology Research, EarlyView.Patients with severe ICI‐induced liver injury are commonly treated with corticosteroids, but the optimal tapering strategy remains uncertain. In this study, a gradual corticosteroid tapering strategy based partly on Japanese clinical practice for autoimmune hepatitis was associated with a low rate of relapse and enabled many patients to safely resume ...Naoto Soma, Yoshihito Uchida, Kayoko Sugawara, Masamitsu Nakao, Nobuaki Nakayama, Yukinori Imai, Suguru Mizuno, Satoshi Mochida +7 morewiley +1 more sourceRapid Intrasegmental Progression After Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma: Incidence, Imaging Features, and Clinical Outcomes
Hepatology Research, EarlyView.ABSTRACT Aim
Radiofrequency ablation (RFA) is curative therapy for early‐stage hepatocellular carcinoma (HCC), but a rare subset of patients develop aggressive intrasegmental recurrence shortly after complete ablation. We characterized the incidence, risk factors, and absolute risk.Takuma Kaneko, Takuma Nakatsuka, Ryosuke Tateishi, Keisuke Mabuchi, Yuki Matsushita, Tomoharu Yamada, Tatsuya Minami, Masaya Sato, Mitsuhiro Fujishiro +8 morewiley +1 more sourceTrends in the Proportion of Hepatitis C Virus Antibody‐Positive Patients Who Could be Considered for Direct‐Acting Antiviral Therapy Identified Through Preoperative Testing for Ophthalmic Surgery: A Nationwide Multicenter Real‐World Cohort Study in Japan
Hepatology Research, EarlyView.Although the number of HCV antibody‐positive patients in ophthalmology departments has decreased, the proportion requiring referral for DAA therapy has not declined despite the widespread use of DAAs. Furthermore, combining HCV antibody titer determination with EMR review improves the efficiency of identifying patients requiring referral.Ritsuzo Kozuka, Yoshihito Uchida, Hatsue Fujino, Akira Asai, Tatsuya Ide, Masaru Enomoto, Hiroki Tojima, Hirokazu Takahashi, Jun Inoue, Tadashi Ikegami, Yoshio Tokumoto, Mizuki Endo, Mika Horino, Ryo Sasaki, Tetsuro Shimakami, Koji Sawada, Kazuhito Kawata, Masatsugu Ohara, Kenji Nagata, Takako Inoue, Satoru Kakizaki, Masaaki Korenaga +21 morewiley +1 more sourceThe very-rapid and the ultra-rapid virologic response to two treatment options in patients with chronic hepatitis C: an interim report of a prospective randomized comparative effectiveness study
, 2015 Mostafa Yakoot,1,2 Alaa M Abdo,3 Ahmed Yousry,4,5 Sherine Helmy61Green Clinic and Research Center, 2Abbas Helmy Clinics, 3Tropical Medicine and Hepatology Department, Alexandria Faculty of Medicine, Alexandria University, 4Microbiology Department, High ...Yousry A, Helmy S, Abdo AM, Yakoot Mcore Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus
We recently identified a polymorphism upstream of interleukin (IL)-28B to be associated with a 2-fold difference in sustained virologic response (SVR) rates to pegylated interferon-alfa and ribavirin therapy in a large cohort of treatment-naive, adherent Kwo, Paul Y., Poynard, Thierry, Muir, Andrew J., Poordad, Fred, Koury, Kenneth, Jacobson, Ira M., Patel, Keyur, Noviello, Stephanie, McCone, Jonathan, Galler, Greg W., King, John W., Nyberg, Lisa M., Pedicone, Lisa D., Goldstein, David B., Esteban, Rafael, Vock, David M., Shianna, Kevin V., Fellay, Jacques, Ge, Dongliang, Ghalib, Reem H., Freilich, Bradley, Afdhal, Nezam H., Brass, Clifford A., Urban, Thomas, Lee, William M., Reindollar, Robert, Shiffman, Mitchell L., Thompson, Alexander J., Tillmann, Hans L., Lawitz, Eric J., Pieper, Karen S., Albrecht, Janice K., Sulkowski, Mark S., Zeuzem, Stefan, McHutchison, John G. +34 morecore +1 more sourceMigration‐related inequalities in HIV diagnosis, treatment initiation and retention in care among migrants in Greece
HIV Medicine, EarlyView.Abstract Objectives
Migrants account for a substantial proportion of people living with HIV in Europe, yet inequalities across the HIV care continuum remain insufficiently characterized. We examined migration‐related differences in HIV diagnosis, treatment initiation and retention in care in Greece.Nikos Pantazis, Varvara Vasalou, Olga Tsachouridou, Vasileios Papastamopoulos, Konstantinos Protopapas, Myrto Astriti, Maria Chini, Mina Psichogiou, Georgios Chrysos, Nikolaos V. Sipsas, Helen Sambatakou, Markos Marangos, Diamantis Kofteridis, Periklis Panagopoulos, Giota Touloumi, on behalf of AMACS, G. Adamis, M. Chini, G. Chrysos, M. Marangos, O. Katsarou, D. Kofteridis, S. Metallidis, P. Panagopoulos, N. Pantazis, A. Papadopoulos, V. Paparizos, V. Papastamopoulos, M. Psichogiou, H. Sambatakou, NV. Sipsas, G. Touloumi +31 morewiley +1 more source